Alnylam Pharmaceuticals (ALNY) Property, Plant & Equipment (Net) (QoQ) (2010 - 2026)

Alnylam Pharmaceuticals (ALNY) Property, Plant & Equipment (Net) (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Alnylam Pharmaceuticals 37.29 Bn 34.28 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.00%
Dec 31, 2025 2.27%
Sep 30, 2025 0.39%
Jun 30, 2025 0.22%
Mar 31, 2025 -0.82%
Dec 31, 2024 -0.83%
Sep 30, 2024 -1.96%
Jun 30, 2024 -1.20%
Mar 31, 2024 -0.49%
Dec 31, 2023 0.09%
Sep 30, 2023 -0.36%
Jun 30, 2023 0.85%
Mar 31, 2023 -0.09%
Dec 31, 2022 1.68%
Sep 30, 2022 1.30%
Jun 30, 2022 0.76%
Mar 31, 2022 0.48%
Dec 31, 2021 3.51%
Sep 30, 2021 3.03%
Jun 30, 2021 1.32%